Yakira Capital Management’s Mersana Therapeutics MRSN Stock Holding History

Yakira Capital Management’s Portfolio MRSN Stock Details MRSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-32,663	Closed	-$945K	–	219
2025 Q4	$945K	Buy	+32,663	New	+$620K	0.32%	70

Other funds holding MRSN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Yakira Capital Management's MRSN Position: Q1 2026 in Review

Yakira Capital Management sold out of Mersana Therapeutics (MRSN) in Q1 2026, closing a stake of 32,663 shares — an estimated $945K sold.

Yakira Capital Management first reported a position in MRSN in Q4 2025 and held it in 1 quarter. The position peaked at $945K in Q4 2025. 1 fund tracked by Wall St. Rank holds MRSN as of Q1 2026.

Yakira Capital Management reported no remaining Mersana Therapeutics position as of Q1 2026 after selling out during the quarter.
Yakira Capital Management sold 32,663 Mersana Therapeutics shares in Q1 2026, an estimated $945K.
Yakira Capital Management first reported a position in Mersana Therapeutics in Q4 2025 and held it in 1 quarter.
Yakira Capital Management's Mersana Therapeutics position peaked at $945K in Q4 2025.
1 fund tracked by Wall St. Rank held Mersana Therapeutics as of Q1 2026.

Based on Yakira Capital Management's 13F filing for Q1 2026, filed 14 May 2026.